6.10
Finanzdaten der Champions Oncology Inc-Aktie (CSBR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.43%
15.04
|
13.99 | 12.36 | 17.04 | 13.49 |
| Cost Of Revenue |
9.17%
7.262
|
7.995 | 7.271 | 6.617 | 7.428 |
| Gross Profit |
29.55%
7.773
|
6.00 | 5.084 | 10.42 | 6.061 |
|
|
16.26%
7.588
|
6.527 | 7.091 | 5.923 | 5.329 |
| Benefits Costs and Expenses |
2.30%
14.78
|
14.45 | 14.32 | 12.52 | 12.75 |
| Costs And Expenses |
2.30%
14.78
|
14.45 | 14.32 | 12.52 | 12.75 |
| Depreciation and Amortization |
0.28%
0.357
|
0.358 | 0.394 | 0.398 | 0.399 |
| Operating Income/Loss |
135.10%
0.185
|
-0.527 | -2.007 | 4.499 | 0.732 |
| Income/Loss From Continuing Operations Before Tax |
156.42%
0.255
|
-0.452 | -1.964 | 4.518 | 0.739 |
| Income Tax Expense/Benefit |
28.57%
0.018
|
0.014 | -0.129 | 0.023 | 0.011 |
| Income/Loss From Continuing Operations After Tax |
150.86%
0.237
|
-0.466 | -1.835 | 4.495 | 0.728 |
|
|
150.86%
0.237
|
-0.466 | -1.835 | 4.495 | 0.728 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
3.33%
-0.031
|
-0.03 | - | - | - |
| Basic Average Shares |
0.03%
13.79
|
13.79 | 0.0391 | 13.70 | 13.59 |
| Diluted Average Shares |
4.85%
14.46
|
13.79 | 0.1341 | 14.36 | 14.02 |
| Basic Earnings Per Share |
166.67%
0.02
|
-0.03 | -0.14 | 0.33 | 0.05 |
| Diluted Earnings Per Share |
166.67%
0.02
|
-0.03 | -0.13 | 0.31 | 0.05 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):